retatrutide fda approval status eli lilly The has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from still in Phase II trials. While early studies have shown promising weight-loss results, retatrutide #elililly #obesity #glp1 #diabetes

Start your intake Why Weight Comes Back After Stopping GLP-1 Medications GLP-1 receptor agonists work by reducing hunger signals in the brain, slowing gastric emptying, and improving blood sugar regulation

Ask specifically if the drug is on your formulary and what the clinical criteria are for approval

Monitor Skin Changes: Regularly check your skin for any unusual pigmentation and consult your provider if you notice any concerns

Definitely a helpful addition to my weight management routine

Stay in a small calorie deficit large deficits cause muscle loss, not fat loss

There is no FDA-approved transdermal GLP-1 receptor agonist, and no peer-reviewed human trials show a patch matching injectable results